4.8 Article

Ubiquitylation of Autophagy Receptor Optineurin by HACE1 Activates Selective Autophagy for Tumor Suppression

Journal

CANCER CELL
Volume 26, Issue 1, Pages 106-120

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2014.05.015

Keywords

-

Funding

  1. National Science Foundation of China [31270828, 31070678]
  2. Ministry of Science and Technology, China [2012CB910800, 2013CB910900, 2010CB912101, 2011CB915501]
  3. NIH [GM095526]
  4. Sanofi-aventis SIBS Young Investigator award
  5. Cancer Center of Xuhui Central Hospital [CCR2012003]
  6. Shanghai Institute of Neurosciences [SKLN-201206]
  7. Instrument Developing Project of the Chinese Academy of Sciences [YZ201339]

Ask authors/readers for more resources

In selective autophagy, receptors are central for cargo selection and delivery. However, it remains yet unclear whether and how multiple autophagy receptors might form complex and function concertedly to control autophagy. Optineurin (OPTN), implicated genetically in glaucoma and amyotrophic lateral sclerosis, was a recently identified autophagy receptor. Here we report that tumor-suppressor HACE1, a ubiquitin ligase, ubiquitylates OPTN and promotes its interaction with p62/SQSTM1 to form the autophagy receptor complex, thus accelerating autophagic flux. Interestingly, the Lys48-linked polyubiquitin chains that HACE1 conjugates onto OPTN might predominantly target OPTN for autophagic degradation. By demonstrating that the HACE1-OPTN axis synergistically suppresses growth and tumorigenicity of lung cancer cells, our findings may open an avenue for developing autophagy-targeted therapeutic intervention into cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available